Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 5/20 | 0.35 |
| ▸ | HTR6 | P50406 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17034981 | 0.86 | LMNA (0.37) | FFAR2L3MBTL1KDM4EALDH1A1GAA | |
| SCHEMBL19009791 | 0.84 | FFAR2 (0.35) | FFAR2L3MBTL1HTTABCB1ABCC1 | |
| SCHEMBL19009783 | 0.81 | ALDH1A1 (0.35) | HTR6HTR1AHTR2AHTR7L3MBTL1 | |
| SCHEMBL19009779 | 0.81 | FFAR2 (0.35) | FFAR2L3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL19009865 | 0.80 | TDP1 (0.36) | FFAR2HTR6HTR1AHTR2AHTR7 | |
| SCHEMBL19009847 | 0.80 | HTR6 (0.36) | FFAR2HTR6L3MBTL1HTTKDM4E | |
| SCHEMBL19009782 | 0.80 | HTR1A (0.33) | FFAR2HTR6HTR1AHTR2AHTR7 | |
| SCHEMBL19009766 | 0.79 | ALDH1A1 (0.37) | L3MBTL1KDM4EALDH1A1HPGDTDP1 | |
| SCHEMBL19009850 | 0.79 | HTR6 (0.35) | HTR6L3MBTL1HTTKDM4EALDH1A1 | |
| SCHEMBL19009727 | 0.77 | ADORA2A (0.41) | L3MBTL1HTTKDM4EHPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170179407-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
| US-20170179407-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170179407-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | FFAR2 4269/4885HTR6 3859/4885HTR1A 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.